Skip to main content
Clinical Trials/NCT02425254
NCT02425254UnknownPhase 4

Preemptive Paracetamol for Postoperative Pain: a Randomised, Double-blind, Two Way Crossover Trial

University of Nottingham0 sites50 target enrollmentStarted: January 2016Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Enrollment
50
Primary Endpoint
Morphine consumption

Study Overview

Brief Summary

The purpose of this study is to test whether a dose of paracetamol given before surgical incision is more effective at reducing postoperative pain and analgesic consumption in cervical spine surgery versus a dose given at the end of surgery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Aged 18-80 years old
  • Patients listed for non-malignant cervical spinal surgery
  • General anaesthesia
  • Capacity to give informed consent
  • Ability to use PCA device and pain score scale
  • ASA I, II and III
  • >50kg in weight

Exclusion Criteria

  • Allergy or sensitivity to paracetamol, proparacetamol or morphine
  • Liver disease
  • Renal disease (creatinine clearance <30ml/min)
  • Bleeding disorder
  • Chronic alcoholism
  • Chronic malnutrition
  • Dehydration
  • G6PD deficiency
  • Hypernatraemia (Na >150)
  • Hypokalaemia (K <3.5) and hyperchloraemia
  • Pregnancy or breast-feeding

Arms & Interventions

Preemptive paracetamol

Experimental

1000mg intravenous paracetamol given ≥15 minutes before surgical incision and intravenous saline 15 minutes before the end of surgery

Intervention: Intravenous paracetamol (Drug)

Preemptive paracetamol

Experimental

1000mg intravenous paracetamol given ≥15 minutes before surgical incision and intravenous saline 15 minutes before the end of surgery

Intervention: Intravenous saline 0.9% (Drug)

Postincision paracetamol

Active Comparator

Intravenous saline ≥15 minutes before surgical incision and 1000mg intravenous paracetamol given 15 minutes before the end of surgery

Intervention: Intravenous paracetamol (Drug)

Postincision paracetamol

Active Comparator

Intravenous saline ≥15 minutes before surgical incision and 1000mg intravenous paracetamol given 15 minutes before the end of surgery

Intervention: Intravenous saline 0.9% (Drug)

Outcomes

Primary Outcomes

Morphine consumption

Time Frame: 24 hours postoperatively

Measured from PCA machine

Secondary Outcomes

  • Time to first analgesic request(24 hours)
  • Nausea and vomiting(24 hours)
  • Pruritus(24 hours)
  • Sedation(24 hours)
  • Urinary retention(24 hours)
  • Allergic reaction(24 hours)
  • Pain score(24 hours)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials